These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26887920)

  • 1. No systemic exposure of transtympanic heparin-binding epidermal growth factor like growth factor.
    Santa Maria PL; Kim S; Yang YP
    Drug Chem Toxicol; 2016 Oct; 39(4):451-4. PubMed ID: 26887920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin Binding Epidermal Growth Factor-Like Growth Factor Heals Chronic Tympanic Membrane Perforations With Advantage Over Fibroblast Growth Factor 2 and Epidermal Growth Factor in an Animal Model.
    Santa Maria PL; Weierich K; Kim S; Yang YP
    Otol Neurotol; 2015 Aug; 36(7):1279-83. PubMed ID: 26075672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Outcomes of Heparin-Binding Epidermal Growth Factor-Like Growth Factor for Regeneration of Chronic Tympanic Membrane Perforations in Mice.
    Santa Maria PL; Gottlieb P; Santa Maria C; Kim S; Puria S; Yang YP
    Tissue Eng Part A; 2017 May; 23(9-10):436-444. PubMed ID: 28142401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin binding-epidermal growth factor-like growth factor for the regeneration of chronic tympanic membrane perforations in mice.
    Santa Maria PL; Kim S; Varsak YK; Yang YP
    Tissue Eng Part A; 2015 May; 21(9-10):1483-94. PubMed ID: 25567607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible pro-inflammatory role of heparin-binding epidermal growth factor-like growth factor in the active phase of systemic sclerosis.
    Hirabayashi M; Asano Y; Yamashita T; Miura S; Nakamura K; Taniguchi T; Saigusa R; Takahashi T; Ichimura Y; Miyagawa T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    J Dermatol; 2018 Feb; 45(2):182-188. PubMed ID: 29044628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antigen-dependent clearance on pharmacokinetics of anti-heparin-binding EGF-like growth factor (HB-EGF) monoclonal antibody.
    Kasai N; Yoshikawa Y; Enokizono J
    MAbs; 2014; 6(5):1220-8. PubMed ID: 25517307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer.
    Miyata K; Yotsumoto F; Fukagawa S; Kiyoshima C; Ouk NS; Urushiyama D; Ito T; Katsuda T; Kurakazu M; Araki R; Sanui A; Miyahara D; Murata M; Shirota K; Yagi H; Takono T; Kato K; Yaegashi N; Akazawa K; Kuroki M; Yasunaga S; Miyamoto S
    Anticancer Res; 2017 Jul; 37(7):3955-3960. PubMed ID: 28668900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of heparin-binding epidermal growth factor-like growth factor increases albuminuria in puromycin aminonucleoside nephrosis.
    Khong TF; Fraser S; Katerelos M; Paizis K; Hill PA; Power DA
    Kidney Int; 2000 Sep; 58(3):1098-107. PubMed ID: 10972674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan/PEI patch releasing EGF and the EGFR gene for the regeneration of the tympanic membrane after perforation.
    Lee MC; Seonwoo H; Garg P; Jang KJ; Pandey S; Park SB; Kim HB; Lim J; Choung YH; Chung JH
    Biomater Sci; 2018 Jan; 6(2):364-371. PubMed ID: 29293256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-binding epidermal growth factor-like growth factor and hepatocyte growth factor inhibit cholestatic liver injury in mice through different mechanisms.
    Sakamoto K; Khai NC; Wang Y; Irie R; Takamatsu H; Matsufuji H; Kosai KI
    Int J Mol Med; 2016 Dec; 38(6):1673-1682. PubMed ID: 27779646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of heparin-binding epidermal growth factor-like growth factor in the adult ovariectomized mouse uterus by progesterone and estrogen.
    Wang XN; Das SK; Damm D; Klagsbrun M; Abraham JA; Dey SK
    Endocrinology; 1994 Sep; 135(3):1264-71. PubMed ID: 8070372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and significance of heparin binding-epidermal growth factor-like growth factor in paclitaxel-resistant ovarian cancer].
    Tang X; Lu M; Li C; Deng S; Li M
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):517-22. PubMed ID: 25327734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Heparin-Binding Epidermal Growth Factor-Like Growth Factor Mediates Liver Fibrosis in Transgenic Mice.
    Guo Y; Ding Q; Chen L; Ji C; Hao H; Wang J; Qi W; Xie X; Ma J; Li A; Jiang X; Li X; Jiang H
    Am J Med Sci; 2017 Aug; 354(2):199-210. PubMed ID: 28864379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of membrane-bound heparin-binding epidermal growth factor-like growth factor (HB-EGF) in renal epithelial cell branching.
    Takemura T; Hino S; Okada M; Murata Y; Yanagida H; Ikeda M; Yoshioka K; Harris RC
    Kidney Int; 2002 Jun; 61(6):1968-79. PubMed ID: 12028437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of heparin binding epidermal growth factor-like growth factor in the early phase of regeneration after acute renal injury. Isolation and localization of bioactive molecules.
    Sakai M; Zhang M; Homma T; Garrick B; Abraham JA; McKanna JA; Harris RC
    J Clin Invest; 1997 May; 99(9):2128-38. PubMed ID: 9151785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance and usefulness of soluble heparin binding-epidermal growth factor in gastric cancer.
    Chung HW; Kong HY; Lim JB
    World J Gastroenterol; 2015 Feb; 21(7):2080-8. PubMed ID: 25717241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High plasma levels of heparin-binding epidermal growth factor are associated with a more stable plaque phenotype and reduced incidence of coronary events.
    Rattik S; Wigren M; Björkbacka H; Fredrikson GN; Hedblad B; Siegbahn A; Bengtsson E; Schiopu A; Edsfeldt A; Dunér P; Grufman H; Gonçalves I; Nilsson J
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):222-8. PubMed ID: 25359857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanadium stimulates human bronchial epithelial cells to produce heparin-binding epidermal growth factor-like growth factor: a mitogen for lung fibroblasts.
    Zhang L; Rice AB; Adler K; Sannes P; Martin L; Gladwell W; Koo JS; Gray TE; Bonner JC
    Am J Respir Cell Mol Biol; 2001 Feb; 24(2):123-31. PubMed ID: 11159045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production.
    Keay S; Kleinberg M; Zhang CO; Hise MK; Warren JW
    J Urol; 2000 Dec; 164(6):2112-8. PubMed ID: 11061938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial separation theory for post-tonsillectomy secondary hemorrhage: evidence in a mouse model and potential heparin-binding epidermal growth factor-like growth factor therapy.
    Beswick DM; Santa Maria C; Ayoub NF; Capasso R; Santa Maria PL
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):569-578. PubMed ID: 29188436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.